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Activation and suppression of the complement system compete
onevery serum-exposed surface, host or foreign.Potentially harm-
ful outcomes of this competition depend on surface molecules
through mechanisms that remain incompletely un-
derstood. Combining surface plasmon resonance (SPR) with
atomic forcemicroscopy (AFM), herewe studied two complement
system proteins at the single-molecule level: C3b, the proteolyti-
cally activated form of C3, and factor H (FH), the surface-sensing
C3b-binding complement regulator. We used SPR to monitor
complement initiation occurring through apositive-feedback loop
wherein surface-deposited C3b participates in convertases that
cleave C3, thereby depositing more C3b. Over multiple cycles of
flowing factor B, factor D, and C3 over the SPR chip, we amplified
C3b from20 to220molecules m2. AFM revealed C3b clus-
ters of up to 20molecules and solitaryC3bmolecules deposited up
to 200nmaway from the clusters. A force of 0.17 0.02 nanonew-
tonswasneeded topull a singleFHmolecule, anchored to theAFM
probe, from its complex with surface-attached C3b. The extent to
which FH molecules stretched before detachment varied widely
among complexes. Performing force-distancemeasurements with
FH(D1119G), a variant lacking one of the C3b-binding sites and
causing atypical hemolytic uremic syndrome, we found that it
detached more uniformly and easily. In further SPR experiments,
KD values between FH and C3b on a custom-made chip surface
were 5-fold tighter than on commercial chips and similar to those
on erythrocytes. These results suggest that the chemistry at the
surface on which FH acts drives conformational adjustments that
are functionally critical.
Within minutes of entering the human bloodstream, foreign
material becomes coated with millions of copies of the protein
C3b (1). C3b (177 kDa) is cleaved from the soluble plasma pro-
tein C3 (185 kDa), themost abundant among the 40 proteins of
the complement system. The presence of numerous C3b mol-
ecules on a cell or particle tags it for clearance (2). At higher
densities, C3b triggers a proteolytic cascade leading eventually,
via cleavage of C5 to C5b, to formation of the potentially cyto-
lytic membrane-attack complex (3). Cleavages of C3 and C5
also generate the pro-inflammatory anaphylatoxins, C3a and
C5a (4).
The swiftness of this evolutionarily ancient response to inva-
sion is vital and relies on the “C3b-amplification loop” (5) (Fig.
1A) that is core to all three activation pathways of the comple-
ment system (6, 7). Many human diseases are linked to inade-
quate regulation of C3b amplification on host surfaces (8).
Numerous approaches are being explored to restore its regula-
tion therapeutically (9), with some candidates well-advanced in
clinical trials (10).
The C3b-amplification loop is initiated by small quantities of
“seed” C3b that arise from continuous low-level fluid-phase
proteolysis ofC3 (see below). This ubiquitous spontaneous pro-
cess underlies the “alternative” pathway (AP)4 of complement
activation (11). Each nascent C3b molecule possesses a thioes-
ter group (12) that is exposed and activated during conversion
of C3 to C3b (13). In its activated form, this thioester will react
with hydroxyl groups in a predominantly indiscriminate fash-
ion on virtually any surface, forming a covalent bond. Alterna-
tively, the thioester gets hydrolyzed, producing soluble
C3b(H2O) (14). Crucially C3b, on surfaces or in fluid phase,
binds factor B (FB), which becomes proteolytically activated by
factor D (FD) to yield C3bBb (Fig. 1A). This complex is called a
C3 convertase because its Bb component cleaves C3 and hence
generates additional C3b that can formmore C3bBb. A related
process generates the seedC3bmentioned above (15); very slow
This work was supported by Leverhulme Trust Grant RPG-2015-109. The
authors declare that they have no conflicts of interest with the contents of
this article.
Author’s Choice—Final versionopenaccessunder the termsof theCreative
Commons CC-BY license.
This article contains supporting information and Figs. S1–S6.
1 Both authors contributed equally to this work.
2 To whom correspondence may be addressed. E-mail: gh23@st-andrews.
ac.uk.
3 To whom correspondencemay be addressed: EaStChem School of Chemis-
try, University of Edinburgh, Joseph Black Chemistry Bldg., Edinburgh,
Scotland EH9 3FJ, United Kingdom. E-mail: Paul.Barlow@ed.ac.uk.
4 The abbreviations used are: AP, alternative pathway; AFM, atomic force
microscopy; CCP, complement control protein module; FB, factor B;
FD, factor D; FH, factor H; PspCN, the N-terminal domain of Streptococ-
cus pneumoniae surface protein C; RU, response units; SAM, self-as-
sembling monolayer; SPR, surface plasmon resonance; FI, factor I; N,
newton(s); (BimC4A)3, tripotassium 5,5,5-[2,2,2-nitrilotris(methylene)-
tris(1H-benzimidazole-2,1-diyl)]tripentanoate hydrate; EDC, N-(3-dimeth-
ylaminopropyl)-N-ethylcarbodiimide hydrochloride; NHS, N-hydroxy-
succinimide; TCEP, tris(2-carboxyethyl)phosphine hydrochloride; TED,
thioester-containing domain.
croARTICLE
Author’s Choice
20148 J. Biol. Chem. (2019) 294(52) 20148–20163
© 2019 Makou et al. Published by The American Society for Biochemistry and Molecular Biology, Inc.
 at U
niv of St A
ndrew
s on January 20, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
hydrolysis of the buried thioester within C3 forms C3(H2O)
that structurally resembles and behaves like C3b (16) in that it
can act as a platform for FB cleavage by FD formingC3(H2O)Bb
in the fluid phase, which converts C3 to C3b and hence seeds
the amplification loop.
Several crucial self-damping properties of the positive-feed-
back C3b-amplification loop ensure that complement activa-
tion remains localized to the initiation site. The C3b thioester
bond is inherently labile, limiting how far nascent molecules
diffuse before either binding to a surface or getting hydrolyzed
(17, 18). Moreover, C3bBb (C3 convertase) turns over C3 rela-
tively slowly (19), and the convertase irreversibly dissociates
into C3b and Bb with a half-life of 90 s, although this is pro-
longed by the protein properdin (19, 20).
Onmost foreign surfaces, the outcome of the AP is normally
rapid accumulation of covalently linked C3b. Thus, the speedy
demise of invading organisms is assured, and the AP is a lag
time–free, antibody-independent first line of defense. Con-
versely, on healthy host cells, the C3b-amplification loop is
strongly suppressed. On damaged, diseased, or dying self cells
and associated cellular debris and waste products (destined for
clearance), C3b amplification is partially suppressed (21). Com-
plement-regulating proteins are the key to this discrimination
between self, nonself, and damaged self (22–25). For instance,
factor H (FH) (26, 27), an abundant 155-kDa serum glycopro-
tein comprised of 20 similar compact modules, competes with
FB for binding to C3b (Fig. 1B), thereby suppressing convertase
formation. FH also accelerates the decay of C3bBb (Fig. 1A).
Once bound to C3b, FH recruits factor I (FI) that cleaves C3b to
C3f and iC3b. iC3b may be further sequentially degraded to
C3dg andC3d that remain surface-bound. Crucially, FHhas the
key property of efficiently regulating C3b amplification on self
surfaces but not on foreign ones (28). On self-surfaces, FH rec-
ognizes sialic acids and glycosaminoglycans as well as iC3b and
C3d (i.e. remnants of a previous regulation event) (27, 29).
Thus, FH selectively protects self-cells, although some bacteria
can hijack FH (30). FH also promotes clearance of damaged self,
but in a noninflammatory manner (21). Here it partly sup-
presses amplification such that lessC3b, andhence lessC3a and
C5a, are produced, whereas the key proteolytic product is iC3b.
iC3b is important for phagocytosis and binds to receptors with
immunosuppressive properties (31). Other complement-regu-
lating proteins, many with related structures and modes of
action (22), are attached to or buried in host cell membranes.
Despite 50 years of effort, C3b amplification and the role of
FH remain incompletely understood. Questions remain about
the dynamic molecular landscape in which FHmust operate to
achieve control of the process. Whereas low numbers of seed
C3b occur on every surface, clusters of C3b are believed to form
during early-stage amplification, wherein C3b progeny sur-
round parental C3 convertases. Although their existence has
been inferred from observations of ferritin-conjugated anti-
C3b antibodies (32), clusters have not been visualized directly.
How quickly do they grow and spread? Do C3b molecules
within a cluster bind each other, forming a mound, or spread
out, forming a one-molecule-thick layer on the surface? Cru-
cially, the mechanism whereby FH focuses its regulatory
actions on self cells rather than foreign ones remains unclear.
Early models invoked selective engagement of FH with C3b
on a self-surface enhanced by co-binding of nearby markers,
such as sialic acids, glycosaminoglycans, and C3b fragments
(24). More recent models hypothesize critical conforma-
tional changes in FH (27, 33, 34).
Herein we establish the utility of combining SPR andAFM to
gain insights into C3b amplification and its regulation. We
observed and counted C3b molecules using AFM, following a
C3b-amplification event controlled and monitored in the SPR
instrument. AFM was also used to detect molecular stretching
and measure forces involved in pulling FH molecules out of
their complexes with C3b. By incorporating into the study cus-
tom-made SPR chips and disease-related and truncation FH
mutants, we investigated the roles of surface chemistry, confor-
mational flexibility, and the two C3b-binding sites of FH.
Results
AFMof C3bmolecules after deposition on SPR sensor chip
We combined SPR and AFM to study the propagation on a
surface of covalently attached C3b molecules (Fig. 1A). In SPR,
responses are directly proportional to the accumulated mass of
molecules on the sensor chip. SPR can thus be used to quanti-
tatively monitor in real time the arrival on the surface of C3b
molecules, generated in situ. If the surface bears hydroxyl
groups to which nascent C3b can form a chemical bond, the
response observed will represent the sum of C3b binding cova-
lently, plus proteins associating reversibly with the surface.
Thus, after washing, remaining signal will originate solely from
covalently bound C3b. To count these molecules and assess
their distribution, we utilized AFM. We used C1 sensor chips
because they lack dextran and have a flat AFM-compatible
surface.
Figure 1. Amplification loop and regulatory role of FH. A, FH intercedes in
thepositive-feedback loopof theAPof complement activationby competing
with FB for binding to C3b, accelerating decay of the convertase C3bBb, and
recruiting factor I (FI) toC3b,whereuponFI cleavesC3b to iC3b (subsequently
further cleaved to C3dg and C3d). B, FH consists of 20 CCP modules (num-
bered) and binds C3b (in fluid phase or on a surface) primarily via two sites, in
CCPs 1–4 and CCPs 19–20. The C-terminal site binds to the TED of C3b that
corresponds to C3d, the ultimate proteolytic degradation product of C3b.
Single-molecule studies of complement regulation
J. Biol. Chem. (2019) 294(52) 20148–20163 20149
 at U
niv of St A
ndrew
s on January 20, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Initially, we aimed to image preformed C3b molecules after
random amine–coupling them to the surface. We coupled 144
response units (RU) of C3b to flow channel 2 of a C1 chip in the
SPR instrument, leaving channel 1C3b-free. To assess the pres-
ence of functional C3b, we flowed over channel 2 a concentra-
tion series of FH solutions, subtracted the signals from channel
1, and inferred aKD assuming a 1:1 complex. This lay within the
previously reported range (Fig. 2A and Table 1) (35–37). The
extrapolated maximum response (Rmax), of 50 RU corre-
sponds to saturation of FH-binding sites on C3b molecules in
the channel. Assuming proportionality betweenmass and RUs,
and based onmolecularmass ratios (FH155 kDa,C3b 177 kDa),
Rmax would be125 RU were each C3b molecule to bind a FH
molecule (155 kDa/177 kDa 144 RU of deposited C3b). Con-
ceivably, only40% (i.e. 100 50/125) of amine-coupled C3b
molecules are orientated in a way that enables them to interact
with FH, or, given that FH has primary C3b-binding sites at
either terminus (35) (Fig. 1B) and a potential third C3b-binding
site in its seventh CCP module (38, 39), some FH molecules
might bind two C3b molecules; formation of a mixture of 1:1
and 1:2 FH:C3b complexes could explain the imperfect fit to a
1:1 model seen in Fig. 2A.
Another C1 chip was identically decorated with 144 RU of
preformed C3b molecules within the SPR instrument but sub-
sequently removed carefully from its cassette for AFM. Fig. 3A
compares AFM images of C3b-free flow channel 1, and channel
2 that bears 144 RU of C3b. The C3b molecules appear on the
flat surface of channel 2 as scattered objects, absent in channel
1. Another flow channel, decorated with 290 RU of C3b,
appeared 2-fold more densely populated (Fig. S1). The diame-
ters of these objects, 12.5  0.3 nm (n  80), are comparable
with the dimensions of aC3bmolecule (10 15 8 nm) (13).
The low height of each object (6 nm) was attributed to mole-
cules drying out and collapsing onto the surface. Thus, most
objects in these AFM images may be attributed to individual
C3b molecules. There are examples of neighboring C3b mole-
cules60 nm apart and some objects that could be C3b dimers
(highlighted in Fig. S1), consistent with the possibility of FH
molecules being able to bind twoC3bmolecules on this surface.
To improve reliability of counting molecules, we adopted a
procedure using phase images. “Soft” proteins showed up well
against the background in phase images (Fig. S1). The summed
surface area, within a 1 1-msquare of theAFM image, for all
signals above a phase threshold (the minimum level that leaves
only proteins visible) was assessed using Gwyddion software.
This was divided by the mean surface area of individual C3b
molecules (12.5-nm diameter circles), yielding 490  20 C3b
molecules m	2 for the 290-RU chip (mean S.D., n 5 1
1-m squares), in reasonable agreement with manual counting
for an example square (Fig. S1). Because SPR correlates with
number of surface molecules, a ratio of 1.7 (490/290) C3b
molecules m	2 per RUwas derived and used in further exper-
iments. Our AFM-assisted C3b count indicates that a rule-of-
thumb equation in which 1 RU  1 pg m	2 (290 RU  870
C3b molecules m	2) would overestimate the number of
bound C3b molecules by80%.
C3b clusters formed in SPR experiments were imaged by AFM
We sought to deposit C3b on a C1 chip in a physiologically
relevantway, using amodified published procedure (40) to gen-
erate the SPR traces in Fig. 2B (another example is shown in Fig.
S2). We amine-coupled to the chip 14 RU of preformed C3b
(Fig. 2B) as a “seed” and then injected a mixture of FB and FD.
We expected FD to rapidly cleave FB within the surface-bound
C3bB complex, yielding C3bBb, the C3 convertase. After elut-
ing FD and Ba (and any intact FB), but before all surface-bound
C3bBb dissociated intoC3b (that stays covalently attached) and
soluble Bb, we flowed C3 over this chip. In a recapitulation of
the AP (Fig. 1A), surviving C3bBb on the surface should cleave
this fresh supply of C3 to C3b. The nascent C3b will either
hydrolyze and be eluted or will react via its activated thioester
with the surface. Over further cycles of pulsing FB/FD and C3,
injection durations were varied to adjust the final RU of accu-
mulated C3b to220, similar to the values achieved by amine
coupling in the previous section.
For each cycle, the SPR trace (Fig. 2B and Fig. S2) reflects (i)
a rise and fall in RU due to formation of surface-bound C3bBb
Figure 2. SPR traces. A, using amine coupling, 144 RU of C3b were immobi-
lizedonaC1chip. TheSPR responsesmeasuredwhile flowinga2-folddilution
series of FH solutions over this surface are shown. The deposited C3b bound
FH with the expected affinity (inset) (see Table 1). B, representative SPR trace
for physiological immobilization of C3b on a C1 chip. Injections were as fol-
lows: 1, EDC/NHS (for activation); 2, C3b (amine coupling, several injections to
achieve 14 RU); 3, ethanolamine; 4, buffer; 5, seven cycles (numbered) of flow-
ing 50 M FB mixed with 50 M FD (B
D) followed by 50 M C3 (3), thus
immobilizing 200 further RU of C3b; 6, 3 M NaCl wash. C, SPR traces for a
dilution series of FH solutions flowed over C3b immobilized on a C1 chip
prepared as shown in B. The inferred KD value is listed in Table 1.
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(forms rapidly from C3bB) and then its partial “decay” (loss of
Bb); (ii) a second gain in RU accompanying C3 injection, being
a combination of reversible C3 binding to C3bBb whereupon
C3 is cleaved to C3b, and covalent deposition of some of that
C3b on the surface; and (iii) a post-C3-injection decline in RU
explained by the continuing departure of Bb (from C3bBb)
along with any free C3 and hydrolyzed C3b. A final high-salt
wash removes noncovalently associated proteins, yielding a sta-
ble SPR signal arising from the original seed C3b plus a growing
number of thioester-immobilized C3b molecules. These accu-
mulated over seven cycles, corresponding to a net gain of205
RU. Two C3b-decorated chips were identically prepared in this
way. One was used to determine by SPR a KD for FH binding to
predominantly physiologically immobilized C3b (Fig. 2C) on a
C1 chip; the other was removed and imaged by AFM (Fig. 3A).
A KD  130 nM for FH binding to C3b on this surface was
estimated from SPR data (compared with KD 230 nM (Table
1) for amine-coupled C3b). The extrapolated Rmax was 50 RU,
implying (as with amine-coupled C3b) either that a portion of
C3bmolecules are unavailable for binding or that one FH strad-
dles two neighboring molecules. By AFM, physiologically
deposited C3b molecules do not show the regular distribution
seen after amine coupling. Instead, 80% lie in discrete, vari-
ably sized and shaped clusters. There are 25 clusters/m2,
with maximum dimensions of 50–200 nm. These are not tall
enough to indicate C3b molecules stacked atop each another.
Countingmoleculeswithin each cluster gave values of 3 to20,
with amedian of 7 (Fig. S3). Remaining, isolated, C3bmolecules
are scattered, with some located 200 nm from a nearest
neighbor.
The rate of C3bmolecule deposition per convertase complex
was approximated during the final cycle of the trace (Fig. 2B).
Flowing FB and FD over the accumulated 165 RU of C3b (280
C3bmolecule m	2, including 25molecules of amine-coupled,
seed C3b) yielded a 45-RU gain. This equates to up to80% of
C3b molecules binding FB, because if every 177-kDa C3b mol-
ecule had a bound 60-kDa Bbmolecule, a gain of 60/177 kDa
165 56RUwas expected (assuming rapid cleavage by FD in all
cases).Hence,225 (0.80 280) convertase complexes atmost
could have been formed m	2. In the 100-s delay before the C3
addition, about half of the convertases decayed, judging from
the trace in Fig. 2B (as anticipated), leaving up to 110 intact
convertases m	2. In the subsequent 60-s step of the cycle,
convertases will have continued to dissociate but still generated
58 RU, or 100 molecules m	2, of immobilized C3b. It follows
that between one and two C3b molecules were deposited s	1
per (surviving) C3bBb.
Preparation of surfaces for adhesion-forcemeasurements
We sought single-molecule information for the FH:C3b
complex by attaching FH to the AFM probe tip. First we coated
gold wafers and AFM cantilevers (note that the probe is part of
the cantilever) by immersion in a solution of alkanethiols that
adsorb to gold, forming a self-assembledmonolayer (SAM).We
used a mixture of alkanethiols (see Fig. S4) expected to give a
SAM with 99 hydroxyl headgroups per carboxyl headgroup on
its exposed surface. We immersed each SAM-coated wafer or
cantilever in a sequence of solutions to achieve protein cou-
pling. PspCN is a bacterial protein domain that binds to the
middle region of FH tightly (34, 41). In most experiments, we
initially thiol-coupled PspCN to maleimide headgroups of the
SAMon the probe and thenused the thiol-coupledPspCNas an
anchor for FH. Alternatively, we amine-coupled FH directly to
the SAM.We generally amine-coupled C3b to the SAM on the
wafer.
Prior to attemptingmanipulations, we imaged these surfaces,
after air drying, byAFM(Fig. S5). SAMs are invisible to contact-
mode AFM; hence, the underlying structure of the gold surface
is evident in SAM-only wafers, with striations corresponding to
layering of the lattices within each gold grain. On C3b-coated
wafers, a loss of visible topographical features of the gold indi-
cated a dense layer of protein molecules (Fig. S5A). We could
not image the CFH-decorated AFM probe tip itself, so we
imaged the cantilever surface.On the cantilever surface bearing
PspCN-anchored FH, AFM revealed numerous objects, many
with a looplike appearance (Fig. S5, B andC). FH is an extended
molecule that comprises 20 “CCP” (42) domains, each 4 nm
long (43), and it has a compact, hinge-like central region (44,
45), so the looped features could be FHmolecules. Their height
of only a few nm suggests a partial collapse of the disulfide-
stabilized protein on the air-dried chip. These observed high
densities of C3b and FH molecules, on the wafer and probe,
Table 1
Summary of the outcomes of SPR experiments on C1 and HJEM-series chips
Chip type (figure) Sample immobilized Sample injected
KD
 S.E.a Offset 2/Rmax
M RU (RU2)/RU
C1 (Fig. 2A) C3b (amine)b; 144 RU FH (2 M -7.8 nM) 0.23 0.03c 14.9 2.8/49.2
C1 (Fig. 2C) C3b (physiological); 196 RU FH (2 M to 7.8 nM) 0.13 0.02c 14.7 5.7/45.1
HJEM2d (Fig. 6A) C3b (amine); 313 RU FH (2 M to 3.9 nM) 0.05 0.01c 38.4 10.9/75.0
HJEM2 (Fig. 6B) C3d (amine); 61 RU FH (2 M to 3.9 nM) 0.64 0.06c 2.1 1.4/61.2
HJEM4 (Fig. 6E) C3b (thiol); 240 RU FH (2 M to 3.9 nM) 0.18 0.02e 9.7 4.6/61.2
HJEM6 (Fig. 6F) FH-PspCN; 18 RU PspCN; 54 RU FH C3b (1 M to 3.9 nM) 0.07 0.01e 2.0 0.3/18.9
HJEM7 C3b (amine); 144 RU FH (2 M to 3.9 nM) 0.07 0.01e 17.1 4.2/57.8
HJEM7 (Fig. 6D) C3b (amine)-3SL (click); 143 RU C3b; 174 RU SL FH (2 M to 3.9 nM) 0.09 0.01e 18.4 6.7/58.4
HJEM7 (Fig. 6C) C3b (amine); 144 RU FH 19–20 (10 M to 3.9 nM) 0.35 0.04e 2.2 0.1/7.3
HJEM7 C3b (amine)-3SL (click); 143 RU C3b; 174 RU SL FH 19–20 (10 M to 3.9 nM) 2.6 0.6e 3.6 0.6/15.0
a S.E. values derived from fitting the data using Biacore software.
b Amine, standard amine coupling; SH, coupling via maleimide; 3’SL (click), 3’ sialyllactose attached using click chemistry; physiological, see legend to Fig. 2C; RU, response
unit.
c Representative data from two or more SPR experiments (in each experiment, duplicate injections at each concentration were performed).
d For specific HJEM chip composition, see Table 2.
e One SPR experiment, with duplicate injections at each concentration, was performed.
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respectively, maximized the likelihood of productive intermo-
lecular encounters during adhesion-force measurements.
Force-distance curves for pulling a CFHmolecule out of a
C3b:CFH complex
To confirm reproducibility of adhesion-force measure-
ments, we decorated multiple AFM probes with PspCN-an-
chored FH and used them to analyze the same C3b-coated
wafer surface (Fig. 4A). Pull-off or detachment events were evi-
dent in90% of the force-distance curves recorded as the FH-
decorated probe was moved across the C3b-bearing surface.
Reassuringly, we found that the adhesion parameters of indi-
vidual detachment events (see below) remained consistent
between identically prepared probes.Weperformed endurance
tests to ascertain whether, over multiple measurements, FH is
shed from the probe or C3b detached from the wafer surface.
Figure 3. Imaging C3bmolecules on an SPR sensor chip. A, a representative AFM phase image of a region of the C1 chip carrying 144 RU of amine-coupled
C3b (right) comparedwith a no-C3bblank surface of the same chip (left). B, three examples of AFMphase images to show the complex C3bmolecule landscape
resulting from the multiple cycles of injections shown in Fig. 2B.
Single-molecule studies of complement regulation
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Figure 4. Force-distance curves for disengaging FH from C3b. A, FH was anchored to PspCN domains attached to a SAM formed on the AFM tip (left),
or FH was randomly amine-coupled directly to a SAM on the AFM tip (right). C3b was amine-coupled to the SAM on the wafer. B, no-FH controls; the tip
lacked PspCN. C, one ofmany force-distance curves collected using the setup in Fig. 4A (left). Because, in this example, the trace does not return abruptly
to baseline, it was not analyzed further.D, additional examples of curves collected using the setup from A (left). Each trace corresponds to the separation
ofmultiple FH and C3bmolecules. Of the components within each curve, those labeled 1were not interpreted. Those labeled 2 and 3, after each of which
the trace returns to the baseline, were considered further. Events labeled 3 could correspond to disengagement of one complex, whereas those labeled
2 correspond to two or more complexes. E, in this example, an event of type 3 involves molecular stretching prior to release. F, the forces for numerous
events of types 2 and 3 are integral multiples of 0.17 nN. G, the distances over which many release events occurred were measured for both setups
shown in Fig. 4A. Release events involving stretching (see E) were plotted separately. These are rarer and occur over longer distances for amine-coupled
FH compared with PspCN-anchored FH.
Single-molecule studies of complement regulation
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The same probe was used repeatedly, and pull-off forces over
several hundred cycles were measured. No detectable deterio-
ration occurred.
Fig. 4 shows examples of force-distance curves obtained
using AFMprobe tips decoratedwith PspCN-anchored FH or a
tip devoid of PspCN that had been immersed in a FH solution
(“blank”) (Fig. 4B). Further negative controls arose from deco-
rating AFM probes with SAM only or with SAM plus PspCN
(i.e. no FH). We detected no adhesion events for any of these.
Relatively high surface densities of protein molecules on both
tip andwafer account for why virtually all force-distance curves
(Fig. 4,C–E), apart from blanks, are complex, corresponding to
interactions between several molecules of FH on the tip and
several of C3b on the wafer. We categorized the primary fea-
tures of these force-distance curves into three types of event.
An initial event (type 1), observed in most curves, has multiple
components and is presumed to arise from numerous interac-
tions; it was not further analyzed. Some subsequent detach-
ment events, defined as types 2 and 3, end with complete relax-
ation (return to zero force) of the cantilever. These could
correspond to individual (type 3) or multiple (type 2) FH mol-
ecules being detached from the C3b-decorated surface,
whereas the final event in each curve (marked with an asterisk
in Fig. 4) represents the very last FH molecule(s) becoming
detached. We analyzed the forces associated with events of
types 2 and 3 (i.e. only considering events where the cantilever
relaxed to zero force afterward and hence not curves such as
those in Fig. 4C). These forces are integral multiples of 0.17 nN
(see Fig. 4F), supporting the notion that events of type 3 (0.17
nN) correspond to single molecules of FH being detached,
whereas events of type 2 (between0.34 and0.68 nN) corre-
spond to between two and four FH molecules becoming
detached from one or more C3b molecules.
Some complexes break apart cleanly, but in other complexes,
stretching of molecules occurs prior to detachment (Fig. 4E).
Indeed, the distances over which putative single pull-off events
occurred range from a few nm to30 nm (Fig. 4G). In parallel
experiments, we amine-coupled FH to the AFM tip (Fig. 4A,
right) instead of using a PspCN anchor, and we observed
detachments occurring over distances up to 60 nm (Fig. 4G).
Such differences in extents of elongation between modes of
FH-tip attachment are expected. Firm and uniform anchoring
of FH, via its central ninth CCP module (46) (of its 20 modules
that are each about 4 nm in length) to PspCNwould limit scope
for stretching. Conversely, some amine-coupled FH molecules
will be tethered to the tip via terminal regions, leaving the other
terminus (modules 1–4 ormodules 19–20) to bindC3b and the
potential for stretching of the intervening segment of 15–17
modules (Fig. 4A). There is also scope for flexibility between the
thioester-containing domain (TED) (binding site for CCPs
19–20) and the rest of the C3bmolecule (binding site for CCPs
1–4) (Fig. 1B) (16, 47).
Measuring FH:C3b and FH:C3d affinities using AFM
We conducted similar experiments on complexes involving
FH, FHmutants, C3b, or C3d (C3d corresponds to the thioester
domain of C3b and is the ultimate cleavage product of C3 in
vivo). We focused exclusively on single-molecule (type 3)
“clean-break” molecular detachments within the resulting
force-distance traces to generate Fig. 5, which displays the dis-
tributions of measured adhesion forces for each AFM tip-wafer
combination. Each plotted data set contains 40–200 measure-
ments, for single-adhesion events, originating from at least two
separately prepared and hence independent AFM probe tips.
From these distributions, a mean S.D. for the force required
to pull apart each complex was determined. The detachment of
PspCN-anchored FH from C3d yields a narrower range of
weaker forces (Fig. 5B) than its detachment fromC3b (Fig. 5A).
As anticipated, the complex between Ox24 (a mAb that recog-
nizes CCPs 1–5) on the wafer and amine-coupled FH on the tip
requiredmore force to disrupt (Fig. 5C) than any other complex
studied. A non-FH-binding antibody control showed, as ex-
pected, nomeasurable interaction. Amine-coupled FHwas less
tightly bound to C3b (Fig. 5D) than was PspCN-anchored FH.
As expected (because it binds FH module 9), PspCN on the tip
interacts with FH 8–15, a FH fragment lacking both of the
primary binding sites for C3b (Fig. 5E), on the wafer. Fig. 5 (A
and F) provides an insightful comparison as the measured pull-
off force for the complex of the disease-linked CFH(D1119G)
mutant with C3b is weaker (Fig. 5F) than the complex of the
WT protein with C3b (Fig. 5A), and the range of values for
individual complexes is narrower. All of these measured adhe-
sion forces were plotted against the logarithm of the relevant
SPR-derivedKDmeasurements (Fig. 5G), revealing good corre-
lation between these two orthogonal means of measuring
interactions.
SPR reveals surface-dependent differences in binding of CFH
to C3b and C3d
All reported SPR-based studies of complement, from the first
such experiments (48) to those described above, utilized sensor
chips from commercial sources. However, details of commer-
cial sensor chipmanufacture and the precise chemical nature of
their surfaces are proprietary information. Our success in
forming SAMs on gold wafers for adhesion-force measure-
ments led us to explore the preparation of bespoke SPR sensor
chips that we called HJEM2, HJEM4, HJEM6, and HJEM7, as
summarized in Table 2.
To create HJEM2, for example, we coated a blank gold SPR
chip with a SAM formed from a 99:1 ratio of hydroxyl-alkane-
thiols/carboxyl-alkanethiols. We used this in SPR-based mea-
surements of FH binding to amine-coupled C3b (313 RU) (Fig.
6A). Unexpectedly, the KD (50  10 nM) (Table 1), was 5-fold
tighter than both the value obtained earlier on a C1 chip (Fig.
2A) and the KD measured on a commercial (C1) chip using the
same C3b loading and identical reagents (not shown). A similar
value of 70 10 nMwas obtainedwhen FHwas flowed overC3b
(144 RU) amine-coupled to a chip (HJEM7; Table 2), with
a higher (25%) carboxyl-group content. A homemade chip
(HJEM4; Table 2) featuring maleimide groups attached to car-
boxyl groups allowed immobilization of hydrolyzed C3b (240
RU) via its free thiol in a quasiphysiological manner. Flowing
FHover this chip (Fig. 6E) gave aKD (180 20nM) similar to the
value reported above for physiologically coupled C3b on the C1
chip (130  20 nM; Table 1). The Rmax values in all of these
experiments (Table 1) suggest—as observed on commercial
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chips—that 27–45% of immobilized C3b molecules on each
HJEM chip could serve as FH-binding sites or that FH binds to
two C3b molecules. The equilibrium data generally fitted less
well to a 1:1 Langmuir model than those collected on commer-
cial chips (comparingX2/Rmax ratios (Table 1)), but this was not
explored further, given the multitude of possible alternative
modes of interaction.
Binding of FH to amine-coupled C3d (61 RU) on a HJEM2
chip fits relativelywell to a 1:1 binding equation, yielding aKDof
0.64 0.06 M (Fig. 6B) and Rmax 61 (suggesting that20%
of C3dmolecules are binding sites). These results contrast with
the reportedly very small responses and extremely low Rmax
values, measured for FH binding to C3d on commercial chips
(35, 49). The two C-terminal modules of FH (FH 19–20) also
bound to amine-coupled C3b on our homemade chips more
tightly (Fig. 6C) (KD 0.35 0.04 M) compared with C3b on
commercial chips (KD 2–4 M) (35).
We had not anticipated these large differences (versus com-
mercial chips) on homemade chips that lacked embellishment
with cell-surface markers such as sialic acids or glycosamino-
Figure5.Adhesion forcesbetweenproteinmolecules. InA–F, AFM-derived adhesion forces (f)weremeasured, binned, andplotted for numerous individual
detachment events of type 3 (see Fig. 4). The y axis (n) is the number of interactions in a bin. A, PspCN-anchored FH on the tip was pulled fromC3b attached to
the wafer. B, as in A, except C3d had been immobilized on the wafer instead of C3b. C, FH was amine-coupled on the tip while on the wafer was amAb (Ox24)
that recognizes CCP 5 of FH.D, as in A, except that FHwas amine-coupled on the tip. E, interaction between PspCN (that binds CCP 9 of FH) and a truncated FH
(CCPs 8–15) on the wafer. F, as in Fig. 5A, except FH was replaced with the mutant D1119G FH. G, the mean adhesion forces displayed in A–F were plotted
against SPR-derived KD values. Error bars, S.D.
Table 2
SAM components used to make four homemade sensor chips for SPR
Chip
type Disulfide SAM Ia Disulfide SAM II Expected SAM headgroup composition
HJEM 2 OH-COOH, 20 M OH-OH, 980 M 1% COOH, 99% OH
HJEM 4 OH-COOH, 20 M OH-OH, 980 M 1% COOH, 99% OH
HJEM 6 OH-propargyl, 20 M OH-OH, 980 M 1% propargyl, 99% OH
HJEM 7 OH-propargyl, 500 M OH-COOH, 500 M 50% OH, 25% COOH, 25% propargyl
a Each disulfide-linked undecanethiol SAM component (see supporting information and Fig. S1) is identified by the chemical natures of its two headgroups (e.g.OH-COOH
has a hydroxyl and a carboxyl headgroup).
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glycans. Nonetheless, we tried making a physiologically rele-
vant surface by preparing a sensor chip (HJEM7; Table 2) fea-
turing propargyl headgroups that we used to click on 174 RU of
3-sialyllactose (in the SPR instrument). As expected, flowing
FH solutions over this surface (lacking C3b or C3d) gave a tiny
response (not shown). On another channel, we first amine-cou-
pled 143 RU of C3b to the chip and then clicked on 174 RU of
3-sialyllactose. From flowing FHover this surface bearing both
C3b and sialic acid, we calculated a KD  90  10 nM for the
CFH:C3b interaction (Fig. 6D) (versus 70 10 nM with no sia-
lyllactose). The Rmax (reflecting howmany C3bmolecules were
available for binding) was the same (58 RUs) irrespective of
3-sialyllactose. This implied that 3-sialyllactose made little
difference to the FH-C3b interaction.
Is there a limit to how tightly CFH binds to C3b?
To further investigate the role of surface context on the
FH:C3b interaction, we chose an SPR-based binding assay in
which FH is immobilized and C3b is in solution. Using a similar
strategy to that employed to anchor FH to the AFM tip
described above, we captured FH (54 RU) with PspCN (18 RU)
that had been clicked via an engineered-in cysteine thiol group
onto propargyl groups on a HJEM6 chip (Table 2). We flowed
C3b over the PspCN-anchored FH and obtained values of KD
(70 nM; Fig. 6F) and Rmax that are consistent with values for
soluble FH binding to C3b immobilized on HJEM chips and
20-fold tighter than a KD reported for C3b flowed over FH that
was randomly amine-coupled to a C1 chip (50).
Discussion
We present, to the best of our knowledge, the first single-
molecule images of C3b distribution following its deposition
and amplification on a surface (Fig. 3B). The formation of
clusters of C3b had previously been inferred from electron
micrographs published more than 50 years ago that showed
ferritin-conjugated anti-C3 antibodies on an erythrocyte
physiologically decorated with C3b (32). The ferritin was
distributed unevenly and included regions where 10–40
Figure 6. Affinity of FHandFH19–20 for C3b immobilized onhomemadeSPR sensor chips. For details of theHJEM series of homemade sensor chips, see
Table 2. For more details of experimental conditions, see Table 1. A, FH injected over C3b amine-coupled to HJEM2; B, FH injected over C3d amine-coupled to
HJEM2; C, construct consisting of FH C-terminal domains 19 and 20 only (FH-19,20) injected over C3b amine-coupled on a HJEM7 chip. D, FH injected over a
composite surface consisting of amine-coupled C3b and 3-sialyllactose. E, FH injected over C3b thio-coupled to maleimide on a HJEM4 chip. F, C3b injected
over PspCN-anchored FH; the PspCN had been attached via click chemistry to a HJEM6 chip.
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molecules occurred within 40–80 nm of cell circumference.
Our AFM images feature two-dimensional clusters, in vari-
ous shapes and sizes, of surface-bound C3bmolecules. A lack
of three-dimensional stacks or clumps shows that nascent
C3b did not use its thioester to bind covalently to the nucleo-
philic groups of already-deposited C3b, under these condi-
tions and at the time chosen to cease activation. This con-
serves—at least during the early phases of activation—access
to the overlapping FB-binding and FH-binding sites on C3b.
Cluster formation is consistent with the short lifespan, rela-
tive to C3b’s diffusion rate, of the exposed and activated thio-
ester group of C3b (13). Immediately post-activation, this
reacts either with surface nucleophiles or with water to form
C3b(H2O) that diffuses away. Thus, C3b can only bind local
surfaces, which is a key spatiotemporal constraint on comple-
ment activation. A quantitative study using 131I-C3b (18)
implied that a maximum of 25 C3b molecules were deposited
on Sepharose beads (a source of hydroxyl groups) for each
immobilized trypsin molecule (a C3 convertase surrogate). In
another experiment (51), nomore than 30C3bmolecules could
be deposited on zymosan (a polysaccharide prepared fromyeast
cell walls) per copy of C3bBb (in a scenario, unlike ours, where
FB was not replenished) despite on-going C3 consumption. It
was suggested that once 25 or 30 copies of C3b had clustered
around a trypsin molecule, or a convertase complex, each new
C3b molecule produced thereafter would be hydrolyzed before
it could diffuse beyond the cluster perimeter. Using a predicted
C3b-diffusion coefficient (52)  4.5 10	7 cm2s	1 and hypo-
thetical radius of 25 nm for a circular, tightly packed cluster of
25 C3bmolecules, a thioester half-life of60s was computed
by these authors and is commonly quoted.
After seven cycles of C3b amplification in our experiments,
AFM revealed 25 clusters, of varying shapes and sizes, per
m2 of the chip surface, each comprised of between three and
20 C3b molecules. These are crowded with few gaps but not,
as presumed (18), closely packed; several clusters were 100
nm across. Because we had just 25 seed C3b molecules m	2
on the chip, we conclude that most seeds had likely nucleated a
cluster. It follows that most of the40 isolated C3b molecules
observed per m2 are new, convertase-generated, molecules.
Some have diffused200 nmbefore touchdown, exceeding the
25-nmmaximum calculated previously (see above). Using Ein-
stein’s approximation equation for two-dimensional diffusion
(t x2/4D, where t represents time,D is the diffusion constant,
and x is distance traveled) and D  4.5 10	7 cm2s	1 for C3b
suggests that a 200-nm journey would require nearly 250 s. A
more rigorous analysis might take into account the flow of liq-
uid over the SPR chip (analogous to the flow of blood over a
physiological surface), but we could not detect any evidence
that the direction of flow had manifested itself in the shapes or
distribution of the observed clusters of C3b molecules. Assum-
ing that we can safely ignore the effects of flow, our results
support a significantly longer half-life of the thioester than the
60 s previously inferred.
In our experiments, we estimated that (after six cycles of
amplification) each convertase caused just one or two C3b
moleculess	1 to be deposited on the surface, when fed 0.5 M
C3 (about one-tenth of the plasma C3 concentration). If, as
suggested (53), one in ten C3b molecules bind to the surface,
then our inferred turnover is 10–20 moleculess	1 per conver-
tase. This aligns with a kinetics study (19) that estimatedKm for
C3  5 M and turnover (kcat)  107 C3 moleculess	1 per
convertase. Thus, combining single-molecule imaging and SPR
illuminates early-stage C3b amplification on surfaces. This
could be explored further (e.g. by varying the composition of
solutions injected, numbers of cycles, injection times, and sur-
face chemistry).
Imaging the growingC3b clusters has provided fresh insights
into the dynamic challenges faced by FH in controlling the
potentially explosively rapid and damaging C3b-amplification
process.We investigated this further by using AFM tomeasure
the forces needed to pull apart complexes of FH and surface-
immobilized C3b. Each force versus distance curve recorded
comprised multiple interactions due to the presence of several
molecules of FH on the AFM probe tip and a high density of
C3b molecules on the wafer (Fig. S5). Importantly, however,
individual detachment events were distinguishable, allowing
force measurement for hundreds of individual complexes.
For individual complexes, “clean breaks” were observed in
which the distance over which the pull off occurred was just
11–15 nm, in addition to instances where50 nmofmolecular
stretching preceded separation (Fig. 4G). The extent of stretch
thus varied between complexes but also depended on whether
FH was randomly amine-coupled or PspCN-anchored specifi-
cally via its ninth module to the tip. For single, clean breaks,
detachment forces ranged from 0.10 to 0.26 nN for PspCN-
anchored FH, with a normal distribution, andmean 0.17 nN,
whereas mean forces measured for multiple pull-off events
were integralmultiples of 0.17 nN. The range of both stretching
distances and, to a lesser extent, detachment forcesmeasured in
these experiments implies multiple kinds of complex forming
between anchored FH and C3b attached to our artificial sur-
face. The existence within FH of two primary C3b-binding sites
(35) joined by 14 CCP modules, each 4 nm long (43) and
linked end-to-end like beads on a string (54), is consistent with
diverse conformational possibilities and variable stoichiome-
try. For example, one FH could bind monovalently (leaving a
site unused) or bivalently to one C3b or bivalently to two C3bs.
The ability of FH to adopt either “open” (binds C3b and C3d;
stabilized by PspCN and some antibodies) or “closed” confor-
mations (does not bind C3d) has been discussed (27, 34, 55, 56).
In support of this model, our observations show that the FH
molecule is indeed a stretchable and conformationally variable
entity.
Force-distance measurements were extended to several
related molecular pairings. A positive control, the FH:anti-FH
antibody interaction, was the tightest, whereas the FH:C3d
interaction was, as expected, the weakest (34). Between these
extremes, we observed that anchoring of FH by PspCN (versus
amine coupling of FH) increases the force needed to separate
FH and C3b, supporting previously reported SPR-based com-
parisons (34). The D1119G mutant (57) of FH, which is linked
to the kidney disease atypical hemolytic uremic syndrome and
inwhich the C-terminal C3b-binding site is perturbed (58), was
detached more easily from C3b thanWT FH. Moreover, a nar-
rower range of complexes are formed by FH(D1119G), com-
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pared with WT (Fig. 4, A versus F), presumably because it con-
tains just one primary C3b-binding site (in CCPs 1–4), thus
reducing the range of complexes that can form. These ob-
servations illustrate the insights offered by single-molecule
approaches and suggest that these are a good way to compare
the C3b-interacting properties of FH mutants.
Reassuringly, AFM-derived binding forces correlate with
SPR-derived affinities (Fig. 5G). Thus, whereas caution is
needed in analyzing whole-population measurements for FH
where differences between subpopulations of distinctly differ-
ent complexes are averaged away, SPR measurements remain
informative. In particular, SPR delivered real-time data reveal-
ing temporal aspects of C3b amplification (Fig. 2B). Moreover,
in SPR, analytes are flowed over ligands covalently attached to a
surface, mimicking the flow of FH, FB, FD, etc. over surface-
tethered C3b. On the downside, commercially available SPR
sensor-chip surfaces are not designed to mimic biological sur-
faces. They are heavily functionalized with carboxyl groups to
provide the negative charge that facilitates preconcentration of
most proteins prior to immobilization and tomaximize loading
capacity. Crucially, it is hard to ascertain, from suppliers,modes
of manufacture or precise chemical compositions of chip sur-
face.We thusmanufactured our own chips dedicated to studies
of complement activation. SPR-basedmeasurements on home-
made chips yielded tighter KD values for both FH:C3b and
FH:C3d than measurements on Biacore C1 or CM5 chips. This
underlines the sensitivity to surfaces of FH, as a C3b binder, con-
sistent with its surface-selective complement regulatory proper-
ties. No additional improvement in FH:C3b affinity accompanied
sialic aciddecorationof thehomemadechip surface.This doesnot
invalidate models in which sialic acids are important for self-sur-
face recognition (59, 60) but demonstrates that these sugars are
not needed for FH to bind tightly to surface-immobilizedC3b. An
“inverse” SPR-based assay, in which PspCN anchored the middle
domains of FH to the chip, and soluble C3b was the analyte,
implies that 50–70 nM binding of C3b is also achievable in this
effectivelyoff-surfacecontext,providedthatFHis “open”and inan
appropriate conformation for binding.
By passing FH over C3b immobilized on our HJEM-series
sensor chips or by flowing C3b over PspCN-anchored FH, we
obtained KD values that are 5–10-fold tighter than in previous
SPR-based literature. Using 125I-FH, Kazatchkine et al. (61)
estimated aKD of 100 nM for FH binding to C3b on sheep eryth-
rocytes that are regarded as selflike cells because they are pro-
tected from complement activation by human FH. On two
surfaces that FH does not protect—zymosan and sheep eryth-
rocytes treated to remove 80% of sialic acids—these authors
reported a 10-fold lower affinity of FH for 80–85% of deposited
C3b molecules (1.2 M in the case of zymosan). Intriguingly,
both DiScipio (also using radiolabeled FH) (51) and Kazatch-
kine et al. (61) estimatedKD values in the range of 17–50 nM for
a minority (15–30%) of the binding sites on C3-decorated
zymosan. Thus, our values are similar to those obtained on the
“selflike” surface of sheep erythrocytes (and to the stronger of
the heterogeneous interactions estimated on zymosan). Con-
versely, the KD values of 0.5–1.5 M obtained by us, and in
numerous other reports of SPR studies performed with com-
mercial chips (62), resemble the weaker interactions observed
on nonself surfaces that are, presumably, insufficient to regu-
late C3b amplification. Further work is now possible to ascer-
tain exactly which features of our homemade surfaces enhance
the FH:C3b interaction and to assess the extent to which our
surfacesmimic self ones in this respect. That FH binds C3d (the
TED of C3b) on homemade chips (and presumably on self-
surfaces in vivo) but not commercial ones indicates that it is the
accessibility of the C terminus of FH that is critically affected by
surface chemistry, as has been suggested elsewhere recently
(27, 34, 56, 63).
These higher-affinity CFH:C3b interactions are compatible
with multiple functional observations. Low-nM CFH is suffi-
cient for half-maximal effects in in vitro DAA assays (37, 50).
Similarly, both fluid-phase assays of factor I-cofactor activity
and co-factor assays performed on the sheep-erythrocyte sur-
face are generally performedwithCFHat a concentration in the
range of 10–20 nM (37, 50). In these in vitro assays of DAA and
CA, FH is acting in the absence of on-going AP activation
because fresh C3 is not being supplied. Notably, much higher,
micromolar, levels of FHare needed to prevent erythrocyte lysis
in assays using FH-depleted normal human serum (37), and
indeed, FH is present at 1–2 M in human blood. In hemolysis-
protection experiments, as in vivo, all AP components includ-
ing C3 and FB are present, and FH operates in “fire-fighting
mode.” Under these circumstances, having abundant FH (20
times the KD) could help ensure that FH achieves blanket cov-
erage of C3bmolecules without becoming depleted or outnum-
bered. Significant interest has developed in potential roles of
the complement system in nonvascular contexts, including in
the eye (64), where levels of all complement proteins—some of
which are produced locally—are orders of magnitude lower
than in blood (65). Whereas the complement cascade presum-
ably cannot operate here, FH’s roles in homeostasis (7, 66)
could be important, and its high-affinity interactions with C3b
may be critical.
In conclusion, we have demonstrated the feasibility and the
power of single-molecule level studies of the amplification of sur-
face-bound C3b and intervention by FH. This is important
because numerous diseases arise from imbalances between com-
plement activation and regulation (9). Biological processes to
ensure appropriate quantities of C3b are deposited on surfaces
seem especially liable to failure, probably because the positive-
feedback loop (5) driving C3b amplification magnifies the conse-
quences of even minor functional dissimilarities between inher-
itedvariantsofparticipatingproteins, includingC3,FB,FH,andFI,
which are numerous and can occur in combination (67, 68). Pre-
dicting the consequences of hundreds of genetic variations
requires molecular understanding, at the level discussed above, of
how these proteins interact on the surfaces where complement
activationandregulationcompete.Suchpredictionswould inform
efforts to design, trial, and bring tomarket anti-complement ther-
apeutics that have hadmixed success to date (10, 69, 70).
Experimental procedures
Reagents
The following were purchased from Sigma-Aldrich
(Merck): anhydrous 200-proof pure ethanol 95%, used for
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cleaning gold substrates and deposition of SAMs; iodoacet-
amide; copper (II) sulfate pentahydrate; (
)-sodium L-ascorbate;
and tripotassium 5,5,5-[2,2,2-nitrilotris(methylene)tris(1H-
benziomidazole-2,1-diyl)]tripentanoate hydrate ((BimC4A)3).
ThermoFisher Scientific supplied streptavidin-horseradish
peroxidase conjugate; N-(3-dimethylaminopropyl)-N-eth-
ylcarbodiimide hydrochloride (EDC); N-hydroxysuccinim-
ide (NHS); and tris(2-carboxyethyl)phosphine hydrochloride
(TCEP-HCl). Cysteine-HCl was from Calbiochem. N-(2-amino-
ethyl) maleimide hydrochloride was fromTCI Chemicals. Azido-
PEG3-maleimideanddibenzocyclooctyne-PEG4-biotinwere from
Jena Bioscience. The SPR amine-coupling kit and the BIAnormal-
izing solution (70% (w/w) glycerol) were fromGEHealthcare. The
SAM components, hydroxyl-PEG6-undecanethiol and carboxy-
PEG6-undecanethiol, used for comparison with in-house synthe-
sized SAMcomponents,were purchased fromDojindoMolecular
Technologies, Inc. Other SAM components were synthesized in-
house (all as described in the supporting information and Fig. S4).
Gold substrates and AFMprobes
The SPR C1 sensor chips and the SIA Kit Au used to prepare
our “HJEM” series of homemade sensor chips (see Table 2)
were purchased fromGEHealthcare. The ultra-flat gold wafers
used for AFM studies were from Platypus Technologies. The
AFM probes used in this study were V-shaped cantilevers with
a nominal spring constant of 0.06 N/m (Cantilever D, SNL-10
Chip, Bruker). AFMprobes were coated, by evaporation, with 5
nm of titanium as adhesion promoter, followed by 50 nm of
gold, before chemical modification.
Proteins
Human FH was isolated from human plasma (TCS Biosci-
ences Ltd.), and its purity was confirmed by SDS-PAGE. Other
human plasma–derived proteins (FB, FD, C3, C3b, and C3d)
were purchased from Complement Technologies, Inc. (Tyler,
TX). They were stored as recommended by the supplier
(	80 °C) and used without further purification. The recombi-
nant full-length FH(D1119G) mutant and recombinant FH
fragments consisting of CCPs 19–20 andCCPs 8–15were pro-
duced in Pichia pastoris and prepared as described (35).
Recombinant sumo-Cys-PspCN was produced in Escherichia
coli as described (34). The conjugate, sumo-Cys-PspCN-azide,
was prepared by reaction of the protein (which contains one
Cys residue) with azido-(PEG)3-maleimide following Jena Bio-
sciences’ instructions. The presence of the azide groupwas con-
firmed as follows. The suspected sumo-Cys-PspCN-azide was
first reacted with iodoacetamide to block any remaining free
thiol groups and then with dibenzocyclooctyne-(PEG)4-biotin;
subsequently, the final conjugated product was detected by
Western blotting with a streptavidin-horseradish peroxidase
conjugate. Anti-FH mAb OX24 was from GeneTex, and goat
anti-C3 polyclonal antibody was from Bioss Antibodies.
Immobilizing C3b on C1 sensor chips for AFM studies and KD
measurements
AC1 sensor chip (GE Healthcare) was docked in the Biacore
T200 instrument. Experiments were conducted at 25 °C. The
running buffer (HBS-P) contained 10 mM HEPES buffer (pH
7.4), 150mMNaCl, 0.05% (v/v) surfactant P20, and 1mMMgCl2.
Typically, one flow channel of the chip was prepared in the
absence of proteins to serve as a reference (blank). C3b was
amine-coupled to a second flow channel after activating the
chip surface with EDC and NHS using standard procedures; to
achieve the desired density of C3b molecules on the surface, a
solution of 1.0 g/ml C3b in acetate buffer, pH 5.0, was repeat-
edly injected at 10 l/min until the target of 150 RUs was
achieved. In a third flow channel on the chip, 18 RU of C3b (to
serve as a “seed”)were amine-coupled (using a 90-s injection, 10
l/min, of 0.5g/ml C3b in acetate, pH 5.0) to the surface. C3b
was then physiologically coupled to the flow channel by inject-
ing (10l/min) amixture of 0.5M FB and 0.5M FD, followed
by a 0.5 M C3 injection in seven sequential cycles as follows:
two cycles of FB and FD for 60 s followed by a C3 injection for
30 s, two cycles of FB and FD for 60 s followed by a C3 injection
for 90 s, and three cycles of FB and FD for 60 s followed by a C3
injection for 120 s. After these seven cycles, 250 RUs of pro-
tein were immobilized. At a flow rate of 30 l/min, 3 M NaCl
was injected for 30 s to remove noncovalently bound proteins
from the surface. After a buffer wash, the cassette was un-
docked, and the chip was carefully removed from the cassette
for AFM. Another C1 chip, subsequently prepared in an iden-
tical way, was left in the SPR instrument and used for measure-
ments of KD (see below).
Preparing homemade (“HJEM-series”) SPR sensor chips
One corner of the gold surface of each new blank gold chip
(GE Healthcare) was scored with a scalpel. This aided orienta-
tion of the chip in subsequent manipulations. Chips were
O2-plasma–cleaned using a Zepto Plasma Surface Technology
instrument (Diener Electronic; settings: 3 mm Hg, 40 W for
180 s). Each chip was placed in a glass vial containing ethanol,
sonicated using aXUBAultrasonicwater bath (Grant) for 300 s,
and rinsed with ethanol. Self-assembled monolayers were pre-
pared by immersing the chip, immediately after cleaning, in an
ethanolic solution containing a mixture of two disulfide-linked
undecanethiol SAM components (of differing chemical com-
positions and ratios; see Fig. S4 and Table 2) at a summed total
disulfide concentration of 1 mM and then incubating for 48 h at
room temperature Subsequently, the SAM-coated chip surface
was cleaned by three cycles of sonication in, sequentially, etha-
nol, ultrapure water, and ethanol again (600 s each). The chip
was dried with an argon stream and stored under argon at 4 °C.
For SPR studies, the chip was carefully mounted in the Biacore
cassette, following the manufacturer’s instructions, ensuring
that the score mark used for chip orientation was concealed by
the adhesive tape used to secure the chip in the cassette.
Characterization of surfaces
Wafers/chips and AFM cantilevers (probes) were gold-
coated and chemicallymodified using identical procedures.We
therefore inferred the efficacy of our gold-coating and SAM-
forming protocols on probes from the results obtained for
wafers.We also characterized the Biacore-supplied blank gold-
coated chips. Before SAM-coating, waferswere slightly rougher
than Biacore blank chips according to AFM (1.2 versus 0.8-nm
root mean square deviation, over a 1.0  1.0-m area). This
Single-molecule studies of complement regulation
J. Biol. Chem. (2019) 294(52) 20148–20163 20159
 at U
niv of St A
ndrew
s on January 20, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
likely arose from the presence of 65-nmAugrains on ourwafers
compared with 40-nm grains on Biacore blanks. As expected,
similar contact-angle values were measured after deposition of
identical SAMs on both wafers and Biacore chips, whereas dif-
ferent contact-angle values were obtained for chemically differ-
ent SAMs. We concluded that whether formed on wafers or
blank chips, monolayers had comparable chemical composi-
tions. Measurements by AFM showed little change in rough-
ness aftermodificationwith SAMs and detected no contamina-
tion, indicating that surfaces remained clean despite successful
modificationwith SAMs.Analysis of X-ray photoelectron spec-
troscopy yielded a composition and stoichiometry in line with
the expected chemical composition of the SAM in each case.
No unexpected elements were detected.
Setting up homemade sensor chips for KD determinations
A normalization procedure was required after docking each
HJEM-series chip into the Biacore T200 instrument and prior
to immobilizing proteins. This involved injecting a BIAnormal-
izing solution (70% (w/w) glycerol) to allow adjustment of the
detector response and compensate for small variations in the
optical system.Toobtain a stable baseline, an overnight runwas
programmed to include five injections (30 s at 50 l/min) of
HBS-P, five of 50 mM NaOH in 1 M NaCl, five of 1 M NaCl, and
finally five of 10 mM glycine, pH 2.5. This cycle of 20 injections
was repeated once.
Amine coupling of C3b to the carboxyl headgroups on
HJEM2 and HJEM7 chips (Table 1) was achieved using EDC/
NHS-based standard techniques. For thiol coupling of C3b, a
flow channel on theHJEM4 chipwas activated by a 7-min injec-
tion (10 l/min) of 0.2 M EDC and 0.05 M NHS followed by
injection (10 l/min) of N-2-aminoethylmaleimide (50 mM in
PBS, pH 6.0) until a signal of 360 RU was obtained. The surface
was then blocked by a seven-minute injection (10l/min) of 1M
ethanolamine, pH 8.5. A 500 g/ml solution of pre-prepared
C3b—a proportion of which contained a free thiol as a result of
thioester group hydrolysis—was dissolved in PBS and injected
(10 l/min) over the flow channel until 236 RU of C3b-SH
became immobilized. Remainingmaleimide groups on the flow
channel surface were blocked by injecting (10 l/min) 50 mM
L-Cys (in 0.1 M acetate, 1 M NaCl, pH 4.0) for 240 s, followed by
a buffer wash.
In separate experiments, we sought to generate a chip surface
more closely resembling host surfaces (e.g. those of extracellu-
lar matrix). To do this, 3-sialyllactose was attached as follows:
a click-chemistry aqueous mixture was made by sequentially
adding CuSO45H2O (1 mM), (BimC4A)3 (2 mM), 3-sialyllac-
tose-azide (10 mM), and sodium acetate (4 mM) (all final con-
centrations). This mixture was incubated for 300 s and then
(using the SPR instrument) injected over the HJEM7 chip (that
has propargyl headgroups; see Table 1) for 30min (1.0l/min).
This gave 162 RU of immobilized 3-sialyllactose. A blocking
step with ethanolamine, pH 8.5 (7 min, 10 l/min), that also
washed away any nonspecifically bound 3-sialyllactose-azide
was followed by a buffer wash with 2 mM EDTA (420 s, 50
l/min) to remove remaining Cu2
. A second flow channel,
with a composite C3b plus 3-sialyllactose surface, was created
(in the T200 instrument) by amine-coupling C3b to theHJEM7
chip first (143 RU, using the above procedure) and then immo-
bilizing 3-sialyllactose-azide (174 RU) using click chemistry
(see Fig. S6 for the SPR trace).
To anchor FH on a sensor chip (and subsequently employ
C3b as analyte), the fusion protein sumo-Cys-PspCN-azidewas
reacted via a copper-catalyzed azide-alkyne 1,3-dipolar
cycloaddition with propargyl groups on the chip surface. The
PspCN domain is known to bind extremely tightly to FH CCPs
8–10. A similar procedure to that used for 3-sialyllactose-az-
ide immobilization was implemented, except 1.0 mg/ml sumo-
Cys-PspCN-azide was added to the click reaction mixture, and
an HJEM6 chip was used, which has 50-fold fewer propargyl
groups than HJEM7 (Table 2). In total, 18 RU of PspCN were
immobilized. A 80 nM solution of FH was injected over the
PspCN, (30 l/min), resulting in 54 RU of anchored FH.
Measuring KD values by SPR
Tomeasure theKD of the FH:C3b complex, inmost cases, FH
was flowed overC3b immobilized onC1 andHJEM-series chips
(Table 2). For these experiments, performed in a Biacore T200
at 25 °C, a 2-fold dilution series of FH, from 0.0039 to 2 M, all
in HBS-P (pH 7.4), were injected (in duplicate, in order of
increasing concentration) for 180 s at 30 l/min, followed by a
dissociation time of 500 s. Another set of measurements was
performed by similarly injecting a 2-fold dilution series of the
fragment FH 19–20 (the C-terminal two CCPs of FH) from
0.0039 to 10 M. The sensor chip surface was regenerated
between individual injections by either three (for the C1 chip)
or six (for HJEM-series chips) 30-s 30-l/min injections of 1 M
NaCl. Baseline drift was corrected by subtracting the signal
obtained from a 0 M FH injection. Data were analyzed using
the Biacore Evaluation software and a 1:1 steady-state binding
model.
Immobilization of FH on the AFM tip
For some AFM experiments, FH was immobilized on the
AFM tip by exploiting its near-irreversible binding to PspCN.
To achieve this, the probe was initially cleaned in ethanol and
then immersed in a 1.0 mM disulfide SAMOH-maleimide (Fig.
S1) for 48 h. It was subsequently rinsed sequentially in ethanol
and PBS, pH 7.0, and then immersed in 100 g/ml Cys-PspCN
plus 2.5 mM tris(2-carboxyethyl)phosphine in PBS, pH 7.0.
After 150 min, the probe was removed, rinsed with PBS, and
then immersed in 50 mM cysteine in 0.1 M sodium acetate (pH
4.0) for 20min to block remaining unreactedmaleimide groups.
After a further PBS rinse, the AFM probe was immersed in a 50
g/ml solution of FH, PBS, pH 7.4, for 1 h prior to a final rinse
with PBS, pH 7.4.
In another series of experiments, FH was amine-coupled to
the AFM probe as follows. The probe was cleaned with ethanol
and immersed for 48 h in a 1 mM SAM-forming solution
expected to produce a monolayer with equimolar disulfide
SAMOH-COOHand disulfide SAMOH-OH. The tip was sub-
sequently removed, rinsed with ethanol and then deionized
water, and immersed in 0.2 M EDC, 0.05MNHS for 7min. It was
then rinsed in deionized water and immersed for 2 h in a solu-
tion of 30 g/ml FH in 10 mM acetate buffer, pH 5.0. Following
a further rinse in deionized water, the AFM probe was
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immersed in 1M ethanolamine, pH8.5, for 7min to cap remain-
ing activated esters, before a final rinse in PBS.
Amutated FHand a truncated version (FH8–15,missing the
first seven and last five of 20 CCP modules in WT FH) were
amine-coupled to the probe tip in a similar way to native FH.
Once prepared, FH-cantileverswere stored in PBS at 4 °C; AFM
probes were always used immediately after the final rinse.
Forcemeasurements
Force-measurement experiments were performed in PBS
using a Dimension FastScan AFMwith the Icon head (Bruker).
Care was taken to ensure that substrates (i.e. protein-decorated
surfaces of gold wafers) and the protein-decorated AFM tips
did not dry out during experiments. All AFM probes, sub-
strates, and buffers to be used in an experiment were kept in the
AFM hood overnight before an experiment. The laboratory
housing the instrument was kept at 22 °C. Care was taken dur-
ing setup and data collection tominimize temperature changes
and drift.
Data were collected using the Dimension FastScan “point-
and-shoot” mode, which allows the collection of force curves
over several 10 10 grids, each grid covering an area of 1 1
m. Forces were measured for grids in a minimum of five areas
randomly selected from across the substrate/wafer surface. For
each combination of protein on the tip and protein on the sub-
strate reported, data were collected using a minimum of two
separately prepared AFM probes.
Variations in retract speeds from 0.2 to 5 m/s and in sur-
face-dwell times (up to 2 s) had no significant effect on the
resulting force data. A trigger point of 0.2 V, approach and
retract speeds of 0.8 ms	1, and surface dwell time of 0.5 s
were selected for all experiments. The same type of cantilever
(SNL-10, cantilever D, Bruker) was used throughout to ensure
comparability between data sets. The cantilever was calibrated
at the end of each experiment to ensure that any damage to the
probe from the calibration process would not hamper data col-
lection. Calibration allowed accurate calculation of forces on
the curves collected with each cantilever. Cantilever stiffness
calibration was performed using the thermal tune method (71,
72). Sensitivity was measured by indentation on a nondeform-
able surface (freshly cleaved mica) in the measurement buffer.
Analysis of AFM data
From each force curve collected, those pull-off events con-
sidered characteristic of unbinding events were selected for
analysis. Other events were not considered. This ensured that
measured adhesion values corresponded to unbinding/detach-
ment events only, although these might involve several inter-
acting molecules on both probe and wafer. Force curves were
analyzed using a home-written MATLAB routine. The cali-
brated force curves allowed pull-off forces for unbinding events
to be extracted from any curve that displayed such an event.
Subsequently, distributions of the magnitudes of the pull-off
forces, for each combination of tip protein and substrate pro-
tein, were produced, and a Gaussian distribution was fitted.
In addition to collection of force data from a given tip pro-
tein-substrate protein combination, a fresh AFM probe
(ULNC-AUHW, ThermoMicroscopes, Sunnyvale, CA) with a
nominal spring constant of 2.1 N/m was used to image the
sample surface under the buffer. These images confirmed
homogeneous coating with protein molecules. Force data were
collected using intermittent contact mode over a range of scan
sizes between 0.5 and 2m2. The open-source software Gwyd-
dion (73) was used for image analysis and presentation.
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